Recently, two researchers offered an exciting breakthrough for epilepsy research. The two researchers who had grants from CURE, where Connie Milstein is on the Board, included Daniela Kaufer, PhD from the University of California at Berkeley and Alon Friedman, MD, PhD from Ben-Gurion University of the Negev in Israel.
Together, these researchers have shown that the drugs known as TGF-beta blockers have prevented epilepsy in rats who experience brain injuries. Should these findings be confirmed in humans, it would mean that the TGF-beta blockers could prevent many cases of epilepsy which occur in accident victims, in soldiers leaving war zones and more.
Their findings have been made possible by the CURE’s program, Prevention of Epilepsy after Traumatic Brain Injury, in partnership with the United States Army Medical Research and Material Command. Now in its third year, this research is intended to look at the impact that traumatic brain injuries have on epilepsy and to develop intervention and treatments against this outcome.
No comments:
Post a Comment